STAA — STAAR Surgical Co Cashflow Statement
0.000.00%
Last trade - 00:00- $867.46m
- $679.93m
- $239.44m
Annual cashflow statement for STAAR Surgical Co, fiscal year end - January 2nd, USD millions except per share, conversion factor applied.
2021 January 1st | 2022 December 30th | 2023 December 29th | 2024 December 27th | 2026 January 2nd | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 5.91 | 38.8 | 21.3 | -20.2 | -80.4 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 15.6 | 22.7 | 25.7 | 30.9 | 56.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.76 | -28.9 | -40.8 | -5.4 | -16.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 21 | 35.7 | 14.6 | 15.7 | -34.2 |
| Capital Expenditures | -8.4 | -18.1 | -18.2 | -23.4 | -5.82 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -138 | 92.5 | -35.8 | 52.2 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -8.4 | -156 | 74.3 | -59.2 | 46.3 |
| Financing Cash Flow Items | — | — | -2.1 | -1.5 | -1.52 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19.6 | 8.3 | 7.42 | 5.72 | -4.55 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 32.5 | -113 | 96.6 | -38.9 | 8.99 |